LED Photobiomodulation Improves Radial Artery Vascular Function in Vitro
LED
Application of Photobiomodulation Therapy by LED Using a Combined Red and Near-infrared Light Spectrum Improves the Vascular Function of the Radial Artery in Vitro
1 other identifier
interventional
30
1 country
1
Brief Summary
LED photobiomodulation therapy (PBMT) is widely recognized for its beneficial effects in several clinical conditions; however, its potential in modulating vascular function is not yet fully established. Objective: This study aimed to evaluate the application of PBMT by LED (light-emittion diode) using a combined red and near-infrared light spectrum, with a focus on improving the vascular function of the radial artery in vitro. Methodology: A total of 30 radial artery segments were studied and divided into three groups of 10 segments: the PBMT LED group combined with red and infrared light (R + IR), the red light (R) group, and the infrared light (IR) group. Prior to light irradiation at wavelengths of 650 nm and 940 nm, vascular function in these segments was pharmacologically inhibited using L-NAME. The drugs phenylephrine, acetylcholine, and sodium nitroprusside were used to determine if irradiation could restore the inhibited vascular functions. Superoxide anion levels, an important reactive oxygen specie (ROS), were measured using a chemiluminescence assay with lucigenin. The bioavailability of nitric oxide was evaluated using a Griess Reagent Kit assay, while nitric oxide production was assessed through the DAF fluorescence assay. The vascular inflammation was determined by the Intercellular Adhesion Molecule 1 (ICAM-1) expression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2025
CompletedFirst Submitted
Initial submission to the registry
April 25, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedJune 27, 2025
June 1, 2025
1.9 years
April 25, 2025
June 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diameter of Isolated Radial Artery Rings (2 mm)
Description of Primary Outcome Measure(s): The primary outcome of this study is the evaluation of vascular compliance during vasodilation of isolated radial artery rings (2 mm in diameter), with a specific focus on the effects of LED photobiomodulation on arterial function.
12 months
Secondary Outcomes (1)
Evaluation of reactive oxygen species (ROS)
12 months
Study Arms (3)
Photobiomodulation Using Red LED Light at 650 nm Wavelength
EXPERIMENTALThe three arms of the study aim to evaluate the effectiveness of different LED light spectra on vasodilation.
Photobiomodulation Using Red LED Light at 940 nm Wavelength
EXPERIMENTALThe three arms of the study aim to evaluate the effectiveness of different LED light spectra on vasodilation.
Photobiomodulation with Combined Red (650 nm) and Infrared (940 nm) LED Light
EXPERIMENTALThe three arms of the study aim to evaluate the effectiveness of different LED light spectra on vasodilation.
Interventions
For the intervention, the isolated arteries were assigned to three experimental groups. The first group (red) was exposed to light at a wavelength of 650 nm for 83 seconds. The second group (infrared) received irradiation at 940 nm for 94 seconds. The third group (mixed) was irradiated with a combination of red (650 nm) and infrared (940 nm) light for 73 seconds.
Eligibility Criteria
You may qualify if:
- Patients undergoing coronary artery bypass grafting using the radial artery
You may not qualify if:
- Patients with poorly compliant radial arteries or those who underwent coronary artery bypass grafting without use of the radial artery were excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of São Paulo Medical School in Ribeirão Preto
Ribeirão Preto, São Paulo, 14049-900, Brazil
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
April 25, 2025
First Posted
June 27, 2025
Study Start
January 12, 2023
Primary Completion
December 21, 2024
Study Completion
February 21, 2025
Last Updated
June 27, 2025
Record last verified: 2025-06